Physician profile
Karl B Kern
NPI 1336248616
$173,543.17
in general payments reported to CMS, 2019-2025
14 companies · $8,189 in 2025
The $8,189 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $20K · 2021: $63K · 2022: $29K · 2023: $11K · 2024: $15K · 2025: $8,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,085 · Travel and Lodging: $2,853 · Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,250.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,085.00 |
| Travel and Lodging | $2,852.78 |
| Food and Beverage | $513.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $76,874.50 | 2019-2023 | Lifesparc |
| C. R. Bard, INC. & Subsidiaries | $53,100.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25,486.11 | 2019-2025 | Lifevest |
| Stryker Corporation | $16,336.18 | 2019-2024 | Lifepak 15 Monitor/Defibrillator, Lucas |
| Medtronic Vascular, INC. | $809.51 | 2019-2020 | |
| Teleflex LLC | $145.04 | 2023 | Guideliner |
| Novartis Pharmaceuticals Corporation | $131.23 | 2024 | |
| Terumo Medical Corporation | $125.38 | 2019 | |
| Abiomed | $122.24 | 2019 | |
| W. L. Gore & Associates, INC. | $118.23 | 2019 | |
| Cardiovascular Systems INC. | $117.65 | 2019 | |
| Abbott Laboratories | $96.50 | 2019 | |
| Edwards Lifesciences Corporation | $65.24 | 2021-2022 | |
| Medtronic, INC. | $15.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Kern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.